PlainRecalls
FDA Devices Critical Class I Ongoing

Cobalt Implantable Cardioverter Defibrillators: a. Cobalt XT VR ICD, Model Numbers: DVPA2D1, DVPA2D4; b. Cobalt XT DR ICD, Model Numbers: DDPA2D1, DDPA2D4

Reported: August 17, 2022 Initiated: June 22, 2022 #Z-1485-2022

Product Description

Cobalt Implantable Cardioverter Defibrillators: a. Cobalt XT VR ICD, Model Numbers: DVPA2D1, DVPA2D4; b. Cobalt XT DR ICD, Model Numbers: DDPA2D1, DDPA2D4

Reason for Recall

There is the potential for reduced shock energy (~79% of programmed energy) during high-voltage (HV) therapy for Cobalt and Crome implantable cardioverter defibrillators (ICDs) and cardiac resynchronization therapy defibrillators (CRT-Ds).

Details

Units Affected
6884 units
Distribution
Worldwide Distribution
Location
Mounds View, MN

Frequently Asked Questions

What product was recalled?
Cobalt Implantable Cardioverter Defibrillators: a. Cobalt XT VR ICD, Model Numbers: DVPA2D1, DVPA2D4; b. Cobalt XT DR ICD, Model Numbers: DDPA2D1, DDPA2D4. Recalled by Medtronic Inc., Cardiac Rhythm and Heart Failure (CRHF). Units affected: 6884 units.
Why was this product recalled?
There is the potential for reduced shock energy (~79% of programmed energy) during high-voltage (HV) therapy for Cobalt and Crome implantable cardioverter defibrillators (ICDs) and cardiac resynchronization therapy defibrillators (CRT-Ds).
Which agency issued this recall?
This recall was issued by the FDA Devices on August 17, 2022. Severity: Critical. Recall number: Z-1485-2022.